Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
AOD-9604 Jump to: Structure | Mechanism | Studies | Pharmacokinetics | Protocols | Limitations | Lead Researcher | References AOD-9604 Peptide Molecular Structure & Chemical Properties AOD-9604 represents a pioneering approach to peptide-based metabolic research, originally developed in the 1990s at Monash University in Australia as a potential anti-obesity therapeutic
These stubborn areas are characterized by several factors including high alpha-2 adrenergic receptor density relative to beta receptors, reduced blood flow, and greater insulin sensitivity leading to efficient fat storage
Follow-up testing: Keep checking B12 levels and adjust treatment as needed, every 3-6 months
[1] If a rash or generalized itching develops, the injection should be halted and the patient evaluated, as it could be a prodrome of a more serious reaction
SLU-PP-332 functions as a small molecule activator of ERR (estrogen-related receptor) family transcription factors, specifically targeting pathways related to cellular energy output and oxidative capacity
US$ 23.01
US$ 21.02
US$ 24.76
US$ 22.12
